Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...
Colossal Biosciences, the Dallas-based biotechnology company known for its bold mission to resurrect extinct species such as ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and provides ...
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
Biotech raises $540M from DRW, ARK Invest for Canton Coin treasury. Shares surge 120% on Super Validator plans.
Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...
Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback